Citation: K. Stahnke et al., CD95 (APO-1 FAS)-MEDIATED APOPTOSIS IN CYTOKINE-ACTIVATED HEMATOPOIETIC-CELLS/, Experimental hematology, 26(9), 1998, pp. 844-850
Authors:
KOPEC K
OROURKE RA
LINN W
NOTTESTAD SY
ONESCHUK L
HECKER S
HERRERA CJ
ZABALGOITIA M
Citation: K. Kopec et al., USE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN ASSESSING AORTIC-VALVE PROSTHESES - COMPARISON WITH EXERCISE ECHOCARDIOGRAPHY, Circulation, 94(8), 1996, pp. 1829-1829
Authors:
SAUERBREY A
HECKER S
VOLM M
MATTERN J
ZINTL F
Citation: A. Sauerbrey et al., PREDICTIVE VALUE OF STATIN, A G(O)-ASSOCIATED CELL-CYCLE PROTEIN IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 272-272
Authors:
BOHLER T
HERR I
NEDEL S
HECKER S
DEBATIN KM
Citation: T. Bohler et al., INCREASED CD95 (APO-1 FAS) LIGAND IN T-CELLS FROM OLIGO-SYMPTOMATIC HIV-1-INFECTED CHILDREN - DOWN-REGULATION FOLLOWING ANTIRETROVIRAL THERAPY/, Blood, 88(10), 1996, pp. 1977-1977
Citation: M. Volm et al., PREDICTIVE VALUE OF STATIN, A G(O)-ASSOCIATED CELL-CYCLE PROTEIN, IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, International journal of cancer, 64(3), 1995, pp. 166-170
Citation: M. Volm et al., ASSOCIATION OF P53 EXPRESSION WITH PROLIFERATIVE ACTIVITY AND POOR-PROGNOSIS IN PATIENTS WITH SQUAMOUS-CELL LUNG CARCINOMAS, International journal of oncology, 5(3), 1994, pp. 533-538
Citation: S. Hecker et al., P53 EXPRESSION AND POOR-PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Anticancer research, 14(6B), 1994, pp. 2759-2761
Citation: S. Hecker, UNITED-STATES UNIONS, TRADE AND INTERNATIONAL SOLIDARITY - EMERGING ISSUES AND TACTICS, Economic and industrial democracy, 14(3), 1993, pp. 355-367